Overview
This lecture provides a comprehensive introduction to the clinical trial process, with an emphasis on the role of Clinical Data Management (CDM), phases and designs of trials, data flow, essential documents, and CRF (Case Report Form) contents.
Clinical Trial Process Overview
- Clinical trials test new products (drugs, devices, vaccines, etc.) for safety and efficacy on human subjects.
- Pre-clinical studies (non-clinical) test products on animals to assess pharmacology and toxicology.
- Approval from regulatory bodies (e.g., FDA via IND application) is required before starting human trials.
- Clinical trials are conducted in three main phases (I–III) before marketing, followed by post-marketing surveillance (Phase IV).
Regulatory Approvals and Applications
- IND (Investigational New Drug Application): Submitted to FDA with pre-clinical and protocol data before human trials.
- NDA (New Drug Application): Submitted after phase III to obtain marketing approval, containing all pre-clinical and clinical data.
Phases and Designs of Clinical Trials
- Phase I: 20–80 healthy volunteers, focus on safety, pharmacokinetics, and pharmacodynamics.
- Phase II: 100–300 patients, assess safety and efficacy.
- Phase III: 1,000–3,000 patients, confirm safety/efficacy in large populations, compare to standard treatments.
- Phase IV: Post-marketing, monitor rare/long-term side effects.
- Design Types: Active/placebo control, single/double/triple-blind, randomized/unrandomized, parallel, crossover, and factorial.
Clinical Data Management (CDM) Workflow
- CDM ensures clinical trial data is clean, accurate, complete, and consistent before submission to regulatory bodies.
- CDM life cycle: Study Startup (setup), Study Conduct, Study Closeout.
- Key startup steps: Study design, eCRF (electronic Case Report Form) design, validation checks, derivation rules, user acceptance testing (UAT).
- Conduct phase: Data entry (site or CDM), validation checks (batch/system), discrepancy management (queries, self-evident corrections), coding (with dictionaries), reconciliation with other databases (e.g., safety, lab).
Case Report Form (CRF) and Data Flow
- CRFs collect clinical trial data from subjects and are designed based on protocol and source documents.
- Data sources: Patient diaries, physician notes, lab reports, etc.
- CRFs are available in paper or electronic format (eCRF); electronic data capture is now standard.
Key CRF Contents
- Header (study ID, subject ID, site, visit, etc.)
- Inclusion/exclusion criteria
- Demographics
- Medical history
- Vital signs, physical examination
- Study drug and concomitant medication details
- Adverse events, serious adverse events
- Lab assessments, questionnaires
- Protocol deviations, study completion
Key Terms & Definitions
- CDM (Clinical Data Management) — Process ensuring clinical trial data quality and regulatory compliance.
- CRF (Case Report Form) — Document/form for collecting trial data from patients.
- IND — Application for FDA approval to start human clinical trials.
- NDA — Application for FDA approval to market a drug.
- Discrepancy — Incorrect, missing, or inconsistent data in CRFs.
- Edit Check/Validation Rule — Automated rule to detect data errors.
- Data Reconciliation — Comparing data across databases (e.g., safety and CDM).
- Blinding — Keeping trial participants/investigators/statisticians unaware of treatment allocation to avoid bias.
Action Items / Next Steps
- Review three sample CRFs as provided.
- Study protocol and CRF contents for each example.
- Prepare for further classes on protocol and investigator brochure contents.
- Complete any assigned assessments or practical exercises in CDM databases.